Our BG Lab had 3 peer reviewed publications, 5 media appearances, and 3 conference presentations in October alone! Subscribe to our monthly newsletter for exciting updates from us! oncologybg.com/2025/11/03/mon…

Which gives you a greater sense of pride? standing on the podium at a meeting presenting new data or sitting in the audience watching a mentee standing on the podium presenting new data?

BG Bishal Gyawali, MD, PhD, FASCO had a great time speaking with Jasmine Kamboj, MD, FASCO for the OncoDaily Empowering Oncologists podcast where he discusses things from cancer #groundshot to financial toxicity to common sense to personal stories. youtu.be/EiU9SLhnvsM?si…

What do people do with all those hundreds of photos of every slide of every speaker that they take at conferences?

Today at #ABC8 ABC Global Alliance meeting, Bishal Gyawali, MD, PhD, FASCO gave a talk on the pros and cons of various endpoints for breast cancer trials.

Thanks Bishal Gyawali, MD, PhD, FASCO for your time and insights. Super valuable ideas and critically important vision around Common Sense Oncology, Ground shot to maximize care around the world and minimize financial toxicity for cancer care… #globalCancerCare #equity Always fun to connect w you and

It was a nice experience speaking at #ABC8 Advanced Breast Cancee Meeting today in Lisbon. I discussed about new issues surrounding various endpoints in breast cancer trials. The feedback from patients, advocates, colleagues and people I respect have motivated me to continue to

In this new Medscape Medscape Oncology blog post, Bishal Gyawali, MD, PhD, FASCO highlights some positive changes he noticed in a couple of new clinical trials reported during #ESMO25. medscape.com/viewarticle/be…

I noted a progression in the reactions to your message at #ABC8 (applause) compared to ABC7. So important that profound knowledge on study design and its implications on treatment recommendations is heard. Thanks for your efforts in moving the field in the right direction.

Indeed. That’s a great observation. Thank you for pointing this out. I have also noticed this in recent years that more and more people are now seeing the problems that we have been pointing out for a long time. The amount of positive response I received yesterday, including

Empowering Oncologists Podcast – From Cancer Groundshots to Financial Toxicity to Common Sense to Personal Stories Bishal Gyawali, MD, PhD, FASCO Jasmine Kamboj, MD, FASCO oncodaily.com/voices/empower… #Cancer #Oncology #OncoDaily #Health #Medicine CancerWorld

Honored to Speak at ABC8 on Evolving Endpoints in Breast Cancer Trials - Bishal Gyawali (Bishal Gyawali, MD, PhD, FASCO) oncodaily.com/voices/405308 #OncoDaily #Oncology #Cancer #Health #Medicine #BreastCancer #MedX

In my new Medscape Oncology column, I have the opportunity to praise 2 RCTs for doing the right thing. Guess which RCTs they are! medscape.com/viewarticle/be… I hope I get these opportunities to praise cancer drug RCTs more often. BG Lab

Beyond the Critique: The ESMO - Eur. Oncology Trials That Got It Right medscape.com/viewarticle/be… via Bishal Gyawali, MD, PhD, FASCO

🚨Just out JNCI, we review 20 years of RCTs in myeloma for lessons in drug development. Surprisingly, head-to-head trials were as likely to be successful as add-on trials. academic.oup.com/jnci/advance-a… #mmsm #myeloma Manni Mohyuddin

How do oncologists in LMICs like India make treatment decisions? Join Bishal Gyawali, MD, PhD, FASCO and colleagues as they discuss quality of evidence, magnitude of benefit, drug prices, FDA approval status and clinical practice guidelines. oncologybg.com/2025/10/26/web…

I write in praise of 2 RCTs. Guess which 2 RCTs they are. medscape.com/viewarticle/be…

A proof of change 🥰

Bishal Gyawali, MD, PhD, FASCO Common Sense Oncology teach me a lot here

Almost felt like I woke up in Nepal. Missing my Himalayas very much today. #BeautifulBanff